Amicus Therapeutics Receives the 2024 New Treatment Award for Pombiliti (cipaglucosidase alfa-atga) + Opfolda (miglustat) at the 20th Annual WORLDSymposium

08.02.2024 - - Award Recognizes Approval of Amicus Therapeutics’ Two-component Therapy for the Treatment of Late-onset Pompe Disease -PRINCETON, N.J., Feb. 08, 2024 (GLOBE NEWSWIRE) - Amicus Therapeutics (Nasdaq: FOLD), today announced that WORLDSymposium has ... Seite 1

Related Keywords

,Drug Administration ,New Treatment Award ,Amicus Therapeutics Chart ,Micus Therapeutics Kurs ,Micus Therapeutics Aktie ,